The current anti-kickback safe harbor for prescription drug rebates would be eliminated in the commercial insurance market under legislation introduced by freshman Sen. Mike Braun, R-Ind., March 5.
The Drug Price Transparency Act (S 657) would apply to private insurance the rebate safe harbor changes contained in a recent proposed rule issued by the HHS Office of Inspector
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?